Is this you? Create Your Porfile
Avatar

Michael John Alberti

Research Triangle Park

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Michael John Alberti is active.

Explore More

Publication

Featured researches published by Michael John Alberti.

Bioorganic & Medicinal Chemistry Letters | 2008

The identification of pyrazolo[1,5-a]pyridines as potent p38 kinase inhibitors

Mui Cheung; Philip A. Harris; Jennifer Gabriel Badiang; Gregory Peckham; Stanley D. Chamberlain; Michael John Alberti; David K. Jung; Stephanie Harris; Neal H. Bramson; Andrea H. Epperly; Stephen A. Stimpson; Michael Robert Peel

A series of pyrazolo[1,5-a]pyridine derivatives was designed and synthesized as novel potent p38 kinase inhibitors. Our approaches towards improving in vitro metabolism and in vivo pharmacokinetic properties of the series are described.

Archive | 2001

Fused pyrazole derivatives bieng protein kinase inhibitors

Michael John Alberti; Ian Robert Baldwin; Mui Cheung; Stuart Cockerill; Philip A. Harris; David Kendall Jung; Gregory Peckham; Michael Robert Peel; Jennifer Gabriel Badiang; Kirk L. Stevens; James Marvin Veal

Organic Letters | 2005

Pyrazolo[1,5-a]pyridines as p38 kinase inhibitors.

Kirk L. Stevens; David K. Jung; Michael John Alberti; Jennifer Gabriel Badiang; Gregory Peckham; Jim M. Veal; Mui Cheung; Philip A. Harris; Stanley D. Chamberlain; Michael Robert Peel

Bioorganic & Medicinal Chemistry Letters | 2005

(1H-Imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: A novel class of potent MSK-1-inhibitors

Mark J. Bamford; Michael John Alberti; Nicholas Bailey; Susannah Davies; David Kenneth Dean; Alessandra Gaiba; Stephen L. Garland; John D. Harling; David K. Jung; Terence A. Panchal; Christopher A. Parr; Jon Graham Anthony Steadman; Andrew K. Takle; James T. Townsend; David M. Wilson; Jason Witherington

Archive | 2003

Benzimidazoles and their use as mitogen-activated- and rho-kinase inhibitors

Michael John Alberti; Stephen GlaxoSmithKline Pharm. Garland; David Kendall Jung; James Marvin Veal; Jason GlaxoSmithKline Witherington

Archive | 2005

Pyrazolopyridines, process for their preparation and use as therapeutic compounds

Michael John Alberti; Stanley D. Chamberlain; Mui Cheung; Kristjan Gudmundsson; Philip A. Harris; Brian A. Johns; David Kendall Jung; Michael Robert Peel; Jennifer Badiang Stanford

Archive | 2006

PYRIDOPYRAZOLOPYRIMIDINE COMPOUNDS AND THEIR USES AS ANTI-CANCER AND ANTI-DIABETE DRUGS

David Kendall Jung; Michael John Alberti

Bioorganic & Medicinal Chemistry Letters | 2015

Corrigendum to “(1H-Imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: A novel class of potent MSK-1-inhibitors” [Bioorg. Med. Chem. Lett. 15 (2005) 3402–3406]

Mark J. Bamford; Michael John Alberti; Nicholas Bailey; Susannah Davies; David Kenneth Dean; Alessandra Gaiba; Stephen L. Garland; John D. Harling; David K. Jung; Terence A. Panchal; Christopher A. Parr; Jon Graham Anthony Steadman; Andrew K. Takle; James T. Townsend; David M. Wilson; Jason Witherington

Archive | 2001

Derivados de pirazol fusionado como inhibidores de la proteina quinasa.

Michael John Alberti; Ian Robert Baldwin; Mui GlaxoSmithKline Cheung; Stuart Cockerill; Stephen Flack; Philip A. Harris; David Kendall Jung; Gregory GlaxoSmithKline Peckham; Michael Robert Peel; Jennifer Badiang Stanford; Kirk GlaxoSmithKline Stevens; James Marvin Veal

Archive | 2001

Derives de pyrazole a structure fusionnee tenant lieu d'inhibiteurs de proteine kinase

Michael John Alberti; Ian Robert Baldwin; Mui Cheung; Stuart Cockerill; Stephen Flack; Philip A. Harris; David Kendall Jung; Gregory Peckham; Michael Robert Peel; Jennifer Badiang Stanford; Kirk L. Stevens; James Marvin Veal

Explore More

Collaboration

Dive into the Michael John Alberti's collaboration.

Top Co-Authors
Avatar

David Kendall Jung

GlaxoSmithKline

View shared research outputs
Top Co-Authors
Avatar

Philip A. Harris

GlaxoSmithKline

View shared research outputs
Top Co-Authors
Avatar

Michael Robert Peel

Research Triangle Park

View shared research outputs
Top Co-Authors
Avatar

Mui Cheung

GlaxoSmithKline

View shared research outputs
Top Co-Authors
Avatar

James Marvin Veal

GlaxoSmithKline

View shared research outputs
Top Co-Authors
Avatar

David K. Jung

Research Triangle Park

View shared research outputs
Top Co-Authors
Avatar

Gregory Peckham

Research Triangle Park

View shared research outputs
Top Co-Authors
Avatar

Ian Robert Baldwin

GlaxoSmithKline

View shared research outputs
Top Co-Authors
Avatar

Stuart Cockerill

GlaxoSmithKline

View shared research outputs
Top Co-Authors
Avatar

Jennifer Badiang Stanford

Stanford University

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge